Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey

BACKGROUND: Hepatitis A virus (HAV) can cause significant pathology in patients with chronic hepatitis B virus (HBV), however, HAV can be prevented by vaccination. The aim of this study was to determine the implication of vaccination against HAV vaccine in patients with chronic hepatitis B. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Tulek, Necla, Ozsoy, Metin, Moroglu, Cigdem, Cagla Sonmezer, Meliha, Temocin, Fatih, Tuncer Ertem, Gunay, Sebnem Erdinc, Fatma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578535/
https://www.ncbi.nlm.nih.gov/pubmed/29201701
http://dx.doi.org/10.5005/jp-journals-10018-1143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578535/
https://www.ncbi.nlm.nih.gov/pubmed/29201701
http://dx.doi.org/10.5005/jp-journals-10018-1143

Ejemplares similares